Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Current Assets: 2022-2025

Historic Current Assets for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $8.6 million.

  • bioAffinity Technologies' Current Assets rose 237.90% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 237.90%. This contributed to the annual value of $2.7 million for FY2024, which is 32.16% down from last year.
  • Per bioAffinity Technologies' latest filing, its Current Assets stood at $8.6 million for Q3 2025, which was up 416.15% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Current Assets peaked at $14.1 million during Q3 2022, and registered a low of $1.7 million during Q2 2025.
  • Moreover, its 3-year median value for Current Assets was $3.9 million (2024), whereas its average is $4.8 million.
  • Per our database at Business Quant, bioAffinity Technologies' Current Assets plummeted by 69.05% in 2024 and then soared by 237.90% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Current Assets (Quarterly) stood at $12.0 million in 2022, then tumbled by 66.79% to $4.0 million in 2023, then plummeted by 32.16% to $2.7 million in 2024, then skyrocketed by 237.90% to $8.6 million in 2025.
  • Its Current Assets stands at $8.6 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.9 million for Q1 2025.